Dr. Ajai Chari, MD
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Plasma Cell Neoplasm
Studies Multiple Myeloma
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Ajai Chari, MD is currently running
Quadruple Drug Therapy
for Multiple Myeloma
This is a single center, open-label, phase 2 study in elderly (age ≥ 70) subjects with newly diagnosed multiple myeloma who are transplant ineligible. Subjects will receive subcutaneous daratumumab, dose-attenuated bortezomib, revlimid, and dexamethasone until confirmed disease progression, discontinuation of study treatment due to unacceptable drug toxicity, or other reasons. Throughout the study, subjects will be monitored closely for adverse events, laboratory abnormalities, and clinical response.
Recruiting1 award Phase 24 criteria
Selinexor + Carfilzomib + Dexamethasone
for Multiple Myeloma
This phase I trial studies the side effects and best dose of selinexor and carfilzomib when given together with dexamethasone in treating patients with multiple myeloma that has returned or does not respond to treatment. Drugs used in chemotherapy, such as selinexor and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be a better treatment for multiple myeloma.
Recruiting1 award Phase 123 criteria
More about Ajai Chari, MD
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ajai Chari, MD has experience with
- Dexamethasone
- Carfilzomib
- Bortezomib
- Daratumumab
- Lenalidomide
- Isatuximab
Breakdown of trials Ajai Chari, MD has run
Plasma Cell Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ajai Chari, MD specialize in?
Ajai Chari, MD focuses on Plasma Cell Neoplasm and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasm has involved treating patients, or patients who are undergoing treatment.
Is Ajai Chari, MD currently recruiting for clinical trials?
Yes, Ajai Chari, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ajai Chari, MD has studied deeply?
Yes, Ajai Chari, MD has studied treatments such as Dexamethasone, Carfilzomib, Bortezomib.
What is the best way to schedule an appointment with Ajai Chari, MD?
Apply for one of the trials that Ajai Chari, MD is conducting.
What is the office address of Ajai Chari, MD?
The office of Ajai Chari, MD is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.